HomeCompareBNGOW vs PEP

BNGOW vs PEP: Dividend Comparison 2026

BNGOW yields 55555.56% · PEP yields 3.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BNGOW wins by $1.3694488476474725e+24M in total portfolio value
10 years
BNGOW
BNGOW
● Live price
55555.56%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.3694488476474725e+24M
Annual income
$1,364,616,913,224,020,300,000,000,000,000.00
Full BNGOW calculator →
PEP
PepsiCo Inc.
● Live price
3.66%
Share price
$155.29
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$144.7K
Annual income
$63,430.49
Full PEP calculator →

Portfolio growth — BNGOW vs PEP

📍 BNGOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBNGOWPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BNGOW + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BNGOW pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNGOW
Annual income on $10K today (after 15% tax)
$4,722,222.22/yr
After 10yr DRIP, annual income (after tax)
$1,159,924,376,240,417,200,000,000,000,000.00/yr
PEP
Annual income on $10K today (after 15% tax)
$311.45/yr
After 10yr DRIP, annual income (after tax)
$53,915.92/yr
At 15% tax rate, BNGOW beats the other by $1,159,924,376,240,417,200,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNGOW + PEP for your $10,000?

BNGOW: 50%PEP: 50%
100% PEP50/50100% BNGOW
Portfolio after 10yr
$6.847244238237362e+23M
Annual income
$682,308,456,612,010,100,000,000,000,000.00/yr
Blended yield
99.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

BNGOW
No analyst data
PEP
Analyst Ratings
1
Strong
15
Buy
28
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+11.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNGOW buys
0
PEP buys
6
PoliticianChamberTickerTypeAmountDate
Sheldon Whitehouse🏛 Senate$PEP▼ Sell$1,001 - $15,0002026-02-23
Sheldon Whitehouse🏛 Senate$PEP▼ Sell$1,001 - $15,0002026-02-23
Julia Letlow🏢 House$PEP▲ Buy$1,001 - $15,0002026-02-05
Julie Johnson🏢 House$PEP▼ Sell$1,001 - $15,0002025-12-18
Jared Moskowitz🏢 House$PEP▼ Sell$1,001 - $15,0002025-12-02
Jared Moskowitz🏢 House$PEP▼ Sell$1,001 - $15,0002025-12-02
Jared Moskowitz🏢 House$PEP▼ Sell$15,001 - $50,0002025-12-02
Julie Johnson🏢 House$PEP▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$PEP▲ Buy$1,001 - $15,0002025-11-05
Scott DesJarlais🏢 House$PEP▼ Sell$1,001 - $15,0002025-10-28
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBNGOWPEP
Forward yield55555.56%3.66%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$1.3694488476474725e+24M$144.7K
Annual income after 10y$1,364,616,913,224,020,300,000,000,000,000.00$63,430.49
Total dividends collected$1.3691317625593198e+24M$125.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BNGOW vs PEP ($10,000, DRIP)

YearBNGOW PortfolioBNGOW Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$5,566,256$5,555,555.56$10,854$514.44+$5.56MBNGOW
2$2,896,015,891$2,890,059,997.69$11,982$758.21+$2896.00MBNGOW
3$1,408,372,313,122$1,405,273,576,118.65$13,526$1,136.44+$1408372.30MBNGOW
4$640,202,141,193,643$638,695,182,818,602.40$15,727$1,741.93+$640202141.18MBNGOW
5$272,022,320,879,523,800$271,337,304,588,446,620.00$19,012$2,750.28+$272022320879.50MBNGOW
6$108,040,039,048,992,300,000$107,748,975,165,651,200,000.00$24,173$4,514.44+$108040039048992.28MBNGOW
7$40,110,958,331,298,180,000,000$39,995,355,489,515,755,000,000.00$32,789$7,793.80+$40110958331298176.00MBNGOW
8$13,920,190,362,947,560,000,000,000$13,877,271,637,533,070,000,000,000.00$48,258$14,354.51+$13920190362947559424.00MBNGOW
9$4,515,826,563,973,900,600,000,000,000$4,500,931,960,285,546,600,000,000,000.00$78,586$28,686.63+$4.5158265639739007e+21MBNGOW
10$1,369,448,847,647,472,600,000,000,000,000$1,364,616,913,224,020,300,000,000,000,000.00$144,688$63,430.49+$1.3694488476474725e+24MBNGOW

BNGOW vs PEP: Complete Analysis 2026

BNGOWStock

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Full BNGOW Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this BNGOW vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNGOW vs SCHDBNGOW vs JEPIBNGOW vs OBNGOW vs KOBNGOW vs MAINBNGOW vs MOBNGOW vs PMBNGOW vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.